During the past decade, Denver Esophageal and Stomach Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Denver Esophageal and Stomach Center" are "Gastroparesis" (2 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Denver Esophageal and Stomach Center" in a lesser frequency.

Most popular intervention types in "Denver Esophageal and Stomach Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Relamorelin" (1 trials) and "Relamorelin 10 μg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Denver Esophageal and Stomach Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Denver Esophageal and Stomach Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Denver Esophageal and Stomach Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Denver Esophageal and Stomach Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".